Tenax Therapeutics to Present Phase 3 LEVEL Trial Results at ESC Congress 2026

Tenax Therapeutics announced it will showcase late-breaking scientific data from its Phase 3 LEVEL clinical trial during upcoming sessions at the European Society of Cardiology Congress.

29 Aug, 12:21 — 29 Aug, 12:21

Post Share

Sources

Showing 1 of 1 sources

taiwan-newsMostly Factual21h ago

Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026 - Taiwan News

Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026 Taiwan News

Read full article →

Tenax Therapeutics to Present Phase 3 LEVEL Trial Results at ESC Congress 2026

Sources

Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026 - Taiwan News

Related Stories

Record-Breaking White Falcon Sells for Dh1.5 Million at Abu Dhabi Auction

UAE Probes Egyptian Bank Branches Following US Money Laundering Warning

South Korean Retail Investors Shift Billions to US Stocks Amid ETF Curbs

HDFC Bank CEO Sashidhar Jagdishan to Step Down in October